DaVita (DVA) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
DaVita · Health Care · ref. ETF XLV · 50 calls · price $182.08
What the company does: DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
📈 DaVita (DVA) stock price
$182.08+43.8% over range
Oct 14, 25low $103.87 · high $240.96Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
60% recommend buying · 5 analysts
📊 JPI status : DaVita has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 DVA price target & analyst consensus — price $182
The price target · all analysts combined (5 targets)
Highest target · 1 firm of 5$270+48.3%
Median target · of 5 targets$220+20.8%
Lowest target · 1 firm of 5$215+18.1%
Current price$182.08
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
5100%
$215 ↔ $270
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Truist Securities — 62% of its targets hit on this sector (263 calls tested). It aims for $215 (+18 %), call made on August 8, 2026, maturing on August 8, 2027 (67 d ago).
The 3 reliable analysts
$220+21 %
The 2 other firms
$245+35 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $220 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy360%
Hold240%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 DVA price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on DVA most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in DVA? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about DaVita? The JPI assistant answers using our backtest data.
📈 DaVita fundamentals: valuation, margins & growth › open the full page
P/E 15.4Net margin 6.0 %Revenue growth +5.2 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 5 %
2023
Rev +5%Profit +23%
2024
Rev +6%Profit +35%
2025
Rev +6%Profit −20%
🔎 Detailed analyses
✅ Historical analyst reliability on DVA
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Barclays ↗ | 100% | +36.7% | 2 |
| Keybanc ↗ | 100% | +20.8% | 2 |
| Deutsche Bank ↗ | 75% | +18.2% | 8 |
| UBS ↗ | 71% | +18.4% | 7 |
| Feltl & Co. | 67% | +18.6% | 3 |
| Goldman Sachs ↗ | 67% | +17.4% | 3 |
| JP Morgan ↗ | 67% | -8.7% | 3 |
| B of A Securities ↗ | 60% | -0.8% | 10 |
| Raymond James ↗ | 50% | +1.1% | 4 |
📊 What $1,000 invested in DaVita would be worth › open the full page
In short — $1,000 invested in DaVita 10 years ago would be worth $3,192 today, i.e. +12%/yr on average. Best year: 2020 (+56%), worst: 2022 (-34%). Price performance, excluding dividends.
If I'd invested $1,000 in DaVita
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,488 | +49% |
| 3 years ago | $2,980 | +198% |
| 5 years ago | $1,895 | +90% |
Return by year (DaVita)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +96% | $1,958 (+96%) |
| 2025 | -24% | $1,488 (+49%) |
| 2024 | +43% | $2,124 (+112%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on DaVita
Loading news…
📋 All analyst calls on DVA
Filtered on — · ✕ show all
▲ Buy · 🎯$220
Price at call : $183.69 — upside +20%
Today : $182.08 — upside +21%
🎯 on DVA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Truist Securities ↗
Aug 7, 26
■ Hold neutral · not a buy · 🎯$215
Price at call : $183.77 — gap to target +17%
Today : $182.08 — gap to target +18%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
■ Equal-Weight neutral · not a buy · 🎯$224
Price at call : $188.69 — gap to target +19%
Today : $182.08 — gap to target +23%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Truist Securities ↗
Jul 14, 26
■ Hold neutral · not a buy · 🎯$250
Price at call : $232.41 — gap to target +8%
Today : $182.08 — gap to target +37%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
▲ Buy · 🎯$270
Price at call : $235.58 — upside +15%
Today : $182.08 — upside +48%
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 10, 27
matures : Jul 10, 27
■ Equal-Weight neutral · not a buy · 🎯$218
Price at call : $232.8 — gap to target -6%
Today : $182.08 — gap to target +20%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
■ Hold neutral · not a buy · 🎯$201
Price at call : $200.54 — gap to target +0%
Today : $182.08 — gap to target +10%
🎯 on DVA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
Truist Securities ↗
May 8, 26
■ Hold neutral · not a buy · 🎯$205
Price at call : $198.93 — gap to target +3%
Today : $182.08 — gap to target +13%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
See the other 42 calls, newest to oldest
■ Equal-Weight neutral · not a buy · 🎯$194
Price at call : $198.93 — gap to target -2%
Today : $182.08 — gap to target +7%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Buy · 🎯$235
Price at call : $198.65 — upside +18%
Today : $182.08 — upside +29%
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
Deutsche Bank ↗
May 6, 26
▲ Buy · 🎯$220
Price at call : $193.88 — upside +13%
Today : $182.08 — upside +21%
🎯 on DVA : 100% (1 call matured) · 📊 on Health : 53.1% · +4.5% (292 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Buy · 🎯$190
Price at call : $149.22 — upside +27%
Today : $182.08 — upside +4%
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Feb 4, 27
matures : Feb 4, 27
■ Equal-Weight neutral · not a buy · 🎯$158
Price at call : $134.73 — gap to target +17%
Today : $182.08 — gap to target -13%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
■ Hold neutral · not a buy · 🎯$133
Price at call : $119.97 — gap to target +11%
Today : $182.08 — gap to target -27%
🎯 on DVA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
■ Equal-Weight neutral · not a buy · 🎯$143
Price at call : $119.02 — gap to target +20%
Today : $182.08 — gap to target -21%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
■ Equal-Weight neutral · not a buy · 🎯$149
Price at call : $126.38 — gap to target +18%
Today : $182.08 — gap to target -18%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 9, 26
matures : Oct 9, 26
B of A Securities ↗
Sep 10, 25
▼ Underperform · 🎯$140
Price at call : $133.24 — upside +5%
Today : $182.08 — upside -23%
Expected +5% · Actual +36% · Reason (≤ −15%) : ✗ No
🎯 on DVA : 33% (3 calls matureds) · 📊 on Health : 48.1% · +2.0% (362 calls)
-36.3%
stock +36% · XLV +18%
matured Sep 10, 26
■ Equal-Weight neutral · not a buy · 🎯$160
Price at call : $127.69 — gap to target +25%
Today : $182.08 — gap to target -12%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
Truist Securities ↗
May 19, 25
■ Hold neutral · not a buy · 🎯$164
Price at call : $144.96 — gap to target +13%
Today : $182.08 — gap to target -10%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : May 19, 26
matures : May 19, 26
■ Equal-Weight neutral · not a buy · 🎯$169
Price at call : $155.05 — gap to target +9%
Today : $182.08 — gap to target -7%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 18, 26
matures : Feb 18, 26
■ Equal-Weight neutral · not a buy · 🎯$164
Price at call : $141.59 — gap to target +16%
Today : $182.08 — gap to target -10%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 31, 25
matures : Oct 31, 25
Truist Securities ↗
Oct 7, 24
■ Hold neutral · not a buy · 🎯$175
Price at call : $157.54 — gap to target +11%
Today : $182.08 — gap to target -4%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Oct 7, 25
matures : Oct 7, 25
Truist Securities ↗
Aug 20, 24
■ Hold neutral · not a buy · 🎯$165
Price at call : $150.6 — gap to target +10%
Today : $182.08 — gap to target -9%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Aug 20, 25
matures : Aug 20, 25
▲ Buy · 🎯$175
Price at call : $140.3 — upside +25%
Today : $182.08 — upside -4%
Expected +25% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
-8.0%
stock -8% · XLV -13%
matured Aug 8, 25
B of A Securities ↗
Aug 7, 24
▼ Underperform · 🎯$145
Price at call : $138.88 — upside +4%
Today : $182.08 — upside -20%
Expected +4% · Actual -7% · Reason (≤ −15%) : ✗ No
🎯 on DVA : 33% (3 calls matureds) · 📊 on Health : 48.1% · +2.0% (362 calls)
+6.8%
stock -7% · XLV -13%
matured Aug 7, 25
■ Hold neutral · not a buy · 🎯$150
Price at call : $142.5 — gap to target +5%
Today : $182.08 — gap to target -18%
🎯 on DVA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 24, 25
matures : Jul 24, 25
Truist Securities ↗
May 15, 24
■ Hold neutral · not a buy · 🎯$150
Price at call : $136.48 — gap to target +10%
Today : $182.08 — gap to target -18%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : May 15, 25
matures : May 15, 25
■ Equal-Weight neutral · not a buy · 🎯$150
Price at call : $137.69 — gap to target +9%
Today : $182.08 — gap to target -18%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 6, 25
matures : May 6, 25
■ Equal-Weight neutral · not a buy · 🎯$133
Price at call : $134.08 — gap to target -1%
Today : $182.08 — gap to target -27%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Mar 6, 25
matures : Mar 6, 25
Truist Securities ↗
Feb 20, 24
■ Hold neutral · not a buy · 🎯$135
Price at call : $123 — gap to target +10%
Today : $182.08 — gap to target -26%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Feb 19, 25
matures : Feb 19, 25
▲ Buy · 🎯$145
Price at call : $122.22 — upside +19%
Today : $182.08 — upside -20%
Expected +19% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+26.9%
stock +27% · XLV -1%
matured Feb 14, 25
▲ Buy · 🎯$134
Price at call : $119.87 — upside +12%
Today : $182.08 — upside -26%
Expected +12% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+31.3%
stock +31% · XLV -0%
matured Feb 13, 25
Truist Securities ↗
Feb 14, 24
■ Hold neutral · not a buy · 🎯$130
Price at call : $123.41 — gap to target +5%
Today : $182.08 — gap to target -29%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Feb 13, 25
matures : Feb 13, 25
▲ Buy · 🎯$113
Price at call : $97.53 — upside +16%
Today : $182.08 — upside -38%
Expected +16% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+61.4%
stock +61% · XLV +10%
matured Nov 16, 24
Truist Securities ↗
Oct 11, 23
■ Hold neutral · not a buy · 🎯$104
Price at call : $73.79 — gap to target +41%
Today : $182.08 — gap to target -43%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Oct 10, 24
matures : Oct 10, 24
▲ Buy · 🎯$142
Price at call : $112.68 — upside +26%
Today : $182.08 — upside -22%
Expected +26% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+21.6%
stock +22% · XLV +10%
matured Aug 6, 24
Truist Securities ↗
Jul 13, 23
■ Hold neutral · not a buy · 🎯$115
Price at call : $103.74 — gap to target +11%
Today : $182.08 — gap to target -37%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 12, 24
matures : Jul 12, 24
■ Market Perform neutral · not a buy · 🎯$100
Price at call : $96.86 — gap to target +3%
Today : $182.08 — gap to target -45%
🎯 on DVA : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : May 14, 24
matures : May 14, 24
Deutsche Bank ↗
May 9, 23
■ Hold neutral · not a buy · 🎯$113
Price at call : $99.27 — gap to target +14%
Today : $182.08 — gap to target -38%
🎯 on DVA : 100% (1 call matured) · 📊 on Health : 53.1% · +4.5% (292 calls)
in progress (365j)
matures : May 8, 24
matures : May 8, 24
Truist Securities ↗
May 9, 23
■ Hold neutral · not a buy · 🎯$100
Price at call : $100.72 — gap to target -1%
Today : $182.08 — gap to target -45%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : May 8, 24
matures : May 8, 24
■ Market Perform neutral · not a buy · 🎯$98
Price at call : $100.72 — gap to target -3%
Today : $182.08 — gap to target -46%
🎯 on DVA : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 8, 24
matures : May 8, 24
B of A Securities ↗
May 9, 23
▼ Underperform · 🎯$96
Price at call : $100.72 — upside -5%
Today : $182.08 — upside -47%
Expected -5% · Actual +35% · Reason (≤ −15%) : ✗ No
🎯 on DVA : 33% (3 calls matureds) · 📊 on Health : 48.1% · +2.0% (362 calls)
-34.9%
stock +35% · XLV +7%
matured May 8, 24
Cowen & Co.
Feb 23, 23
▲ Outperform · 🎯$90
Price at call : $82.31 — upside +9%
Today : $182.08 — upside -51%
Expected +9% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 100% (1 call matured) · 📊 unranked overall
+51.8%
stock +52% · XLV +14%
matured Feb 23, 24
Truist Securities ↗
Feb 23, 23
■ Hold neutral · not a buy · 🎯$90
Price at call : $82.87 — gap to target +9%
Today : $182.08 — gap to target -51%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Feb 23, 24
matures : Feb 23, 24
Truist Securities ↗
Oct 31, 22
■ Hold neutral · not a buy · 🎯$75
Price at call : $69.87 — gap to target +7%
Today : $182.08 — gap to target -59%
🎯 on DVA : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Oct 31, 23
matures : Oct 31, 23
■ Equal-Weight neutral · not a buy · 🎯$81
Price at call : $73.01 — gap to target +11%
Today : $182.08 — gap to target -56%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 31, 23
matures : Oct 31, 23
■ Neutral neutral · not a buy · 🎯$74
Price at call : $73.01 — gap to target +1%
Today : $182.08 — gap to target -59%
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 31, 23
matures : Oct 31, 23
▲ Buy · 🎯$117
Price at call : $93.21 — upside +26%
Today : $182.08 — upside -36%
Expected +26% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+9.3%
stock +9% · XLV +1%
matured Aug 19, 23
■ Equal-Weight neutral · not a buy · 🎯$103
Price at call : $85.31 — gap to target +21%
Today : $182.08 — gap to target -43%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Aug 4, 23
matures : Aug 4, 23
Deutsche Bank ↗
Aug 2, 22
▲ Buy · 🎯$97
Price at call : $84.8 — upside +14%
Today : $182.08 — upside -47%
Expected +14% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 100% (1 call matured) · 📊 on Health : 53.1% · +4.5% (292 calls)
+19.8%
stock +20% · XLV +1%
matured Aug 2, 23
Frequently asked questions
Should I buy DaVita stock?
This isn't buy advice. For DaVita, the analyst consensus is "Buy", with an average price target of $220 (+21% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on DaVita). We show the numbers — you decide.
Is it too late to buy DaVita? How high can it go?
The most bullish analyst target on DaVita is $270 (+48% above today's price); the average is $220. That's the upside they see. Check how reliable those analysts have actually been on DaVita on our site before trusting it.
Is DaVita still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on DaVita, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in DaVita? The case for and against
The arguments for and against, one by one, from the numbers: why invest in DVA (and why hesitate).
What has DaVita's past performance been?
Historical returns and a "how much if I had invested" calculator: DVA performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX